Xin Lang Cai Jing·2026-03-31 09:57Core Viewpoint - Fosun International reported a significant loss for the fiscal year 2025, with a revenue decline of 9.74% and a loss of 23.396 billion RMB, marking a 437.86% increase in losses year-on-year. The chairman attributed the losses to non-cash impairment charges rather than a deterioration in operational fundamentals [1][5][6]. Financial Performance - For the fiscal year 2025, Fosun International achieved total revenue of 173.425 billion RMB, down from the previous year [1][5]. - The company recorded a loss attributable to shareholders of approximately 23.396 billion RMB, which is a substantial increase compared to the previous year's losses [1][5]. - The core businesses, including pharmaceuticals and insurance, continue to show stable growth despite the overall financial downturn [6]. Business Segments - The four core enterprises of Fosun International—Fosun Pharma, Yuyuan, Fosun Portugal Insurance, and Fosun Tourism—generated a total revenue of 128.2 billion RMB, accounting for 74% of the group's total revenue, an increase of 3% year-on-year [2][6]. - Fosun Pharma's innovative drug revenue reached 9.893 billion RMB, a year-on-year increase of 29.59%, representing 33.16% of the pharmaceutical business revenue [2][6]. - Fosun Portugal Insurance reported a gross premium income of 6.53 billion EUR, with a net profit of 201 million EUR, reflecting a 15.8% increase [2][7]. - Domestic insurance companies under Fosun, including Fosun Baodexin Life, achieved a premium income of 13.28 billion RMB, up 41.6%, and a net profit of 650 million RMB, a 492% increase [7]. Strategic Initiatives - The chairman described the impairment charge as a "roof repair on a sunny day," indicating a proactive approach to address past investment misalignments and refocus resources on high-growth sectors [2][6]. - Fosun aims to gradually restore a profit scale of 10 billion RMB and reduce total group liabilities to below 60 billion RMB, targeting an "investment-grade" rating [3][7]. Stock Buyback - Fosun International is increasing its share buyback efforts to instill market confidence, planning to repurchase shares worth up to 1 billion HKD following the 2025 annual results announcement [4][8].